The comprehensive non-invasive solution for advanced assessment of liver diseases.
The new spleen stiffness measurement (SSM by VCTE™) and the built-in ultrasound localization system allow risk stratification of patients with advanced chronic liver disease and portal hypertension.
Powered by LSM by VCTE™ (Transient Elastography with Controlled Vibration), CAP™ (Controlled Attenuation Parameter), and SSM by VCTE™ for assessment of liver fibrosis, hepatic steatosis, and portal hypertension.
SSM by VCTE™ is unique, patented, and validated for portal hypertension assessment. It is a new marker for non-invasive assessment of spleen stiffness. 109 peer-reviewed publications support the use of SSM by VCTE™.
LSM by VCTE™ is unique, patented, and validated for liver fibrosis assessment. It is the GOLD Standard non-invasive method for liver stiffness assessment with 3,245 international peer-reviewed publications.
CAP™ is the only patented and validated method for hepatic steatosis assessment with 822 international peer-reviewed publications.
